Organon Completes Agreement to License MIUDELLA®, Sebela Pharmaceuticals’ Hormone-Free Intrauterine Device

Key Takeaway: Organon has finalized an agreement to license MIUDELLA®, a hormone-free intrauterine device developed by Sebela Pharmaceuticals. This collaboration aims to enhance Organon's portfolio in women's health. The details regarding the financial terms of the agreement have not been disclosed.